Publications by authors named "Mario Ribezzi"

Claim this Profile
P
Probiotics to reduce ventilator-associated pneumonia in adults with acute non‑anoxic brain injury: Study Protocol for a Double-Blind Multicenter Randomized International Clinical Trial (PROACT).
Alberto Corriero, Rossana Soloperto, Mariateresa Giglio, Michele Salvagno, Paolo Trerotoli, Mario Ribezzi

Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between oral lesions and severe SARS-CoV-2 infection in intensive care unit patients.
Gianfranco Favia, Giuseppe Barile, Angela Tempesta, Chiara Copelli, Gianluigi Novielli, Mario Ribezzi

Oral Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beneficial effects of recombinant CER-001 high-density lipoprotein infusion in sepsis: results from a bench to bedside translational research project.
Alessandra Stasi, Marco Fiorentino, Rossana Franzin, Francesco Staffieri, Sabrina Carparelli, Mario Ribezzi

BMC Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cavernous Sinus Involvement and Near Miss Mediastinitis following Mandibular Tooth Infection Treated during the COVID-19 Pandemic: Clinical Diagnosis and Treatment.
Alessio Danilo Inchingolo, Sabino Ceci, Luisa Limongelli, Alberto Corriero, Luigi Curatoli, Mario Ribezzi

Case Rep Dent· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast.
Alessio Danilo Inchingolo, Giuseppina Malcangi, Sabino Ceci, Assunta Patano, Alberto Corriero, Mario Ribezzi

Int J Mol Sci· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Variants in Critically Ill Patients: A Comparison of the Delta and Omicron Variant Profiles.
Alberto Corriero, Mario Ribezzi, Federica Mele, Carmelinda Angrisani, Fabio Romaniello

Infect Dis Rep· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison between fenoldopam and low-dose dopamine in early renal dysfunction of critically ill patients.
Nicola Brienza, Vincenzo Malcangi, Lidia Dalfino, Paolo Trerotoli, Clementina Guagliardi, Mario Ribezzi

Crit Care Med· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis